Potent anti-inflammatory activity of 3-aminovinylphosphonates as inhibitors of reactive oxygen intermediates, nitric oxides generation, and tumor necrosis factor-alpha release

European Journal of Pharmacology

Volumn 556, Issue 1-3, 2007, Pages 9-13

  Quntar, Abed Al Aziz Al ^a   Gallily, Ruth ^b   Katzavian, Galia ^b   Srebnik, Morris ^a  

^a Faculty of Medicine   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Aminovinylphosphonate; Anti inflammatory; Hydroxyvinylphosphonate; Nitric oxide; Reactive oxygen intermediate; Tumor necrosis factor alpha

Indexed keywords

2 (3 HYDROXY 3 PHENYLPROPYL)HEX 1 ENYLPHOSPHONATE; HYDROXYL GROUP; NITRIC OXIDE; PHOSPHONIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; EVALUATION; FEMALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; FEMALE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PHOSPHONIC ACIDS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; VINYL COMPOUNDS;

EID: 33846097671     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.10.041     Document Type: Article

References (23)

1. Avron A., and Gallily R. Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages. J. Leukoc. Biol. 57 (1995) 264-268
2. Babine R.E., and Bender S.L. Molecular recognition of protein-ligand complexes. Applications to drug design. Chem. Rev. 97 (1997) 1359-1472
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
4. Dembitsky V.M., Quntar A.A., Haj-Yehia A., and Srebnik M. Recent advances in the synthesis and transformations of vinylphosphonates. Mini. Rev. Org. Chem. 2 (2005) 91-109
5. Duan J.J.W., Chen L., Wasserman Z.R., Lu Z., Liu R.Q., Covington M.B., Qian M., Hardman K.D., Magolda R.L., Newton R.C., Christ D.D., Wexler R.R., and Decicco C.P. Discovery of γ-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor α converting enzyme: design, synthesis, and structure-activity relationships. J. Med. Chem. 45 (2002) 4954-4957
6. Eigler A., Sinha B., Hartmann G., and Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today 18 (1997) 487-492
7. Ferrero R.L., and Philpott D.J. Nod1 signaling to extracellular mucosal bacteria in epithelial cells. QInt. Congr. Ser. 1285 (2005) 68-77
8. Holstein S.A., Cermak D.M., Wiemer D.F., Lewis K., and Hohl R.J. Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase. Bioorg. Med. Chem. 6 (1998) 687-694
9. Lowenstein C.J., Dinerman J.L., and Snyder S.H. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120 (1994) 227-237
10. MacMicking J., Zie Q., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
11. Mechoulam R., Parker L., and Gallily R. Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol. 42 (2002) 11-19
12. Michaelidou A.S., and Hadjipavlou-Litina D. Nonsteroidal anti-inflammatory drugs (NSAIDs): a comparative QSAR study. Chem. Rev. 105 (2005) 3235-3271
13. Moreland L.W., Baumgartner S.W., Schiff M.H., Tindall E.A., Fleischmann R.M., Weaver A.L., Ettlinger R.E., Cohen S., Koopman W.J., Mohler K., Widmer M.B., and Blosch C.M. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337 (1997) 141-147
14. Moss M.L., Jin S.-L.C., Milla M.E., Burkhart W., Carter H.L., Chen W.-J., Clay C.W., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.-L., Warner J., Willard D., and Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385 (1997) 733-736
15. Murray H.W., and Cohn Z.A. Mononuclear phagocyte antimicrobial and antitumor activity: the role of oxygen intermediate. J. Invest. Dermatol. 74 (1980) 285-288
16. Poderoso J.J., Carreras M.C., Schopfer F., Lisdero C.L., Riobo N.A., Giulivi C., Boveris A.D., Boveris A., and Cadenas E. The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance. Free Radic. Biol. Med. 26 (1999) 925-935
17. Pope S.M., Brandt E.B., Mishra A., Hogan S.P., Zimmermann N., Matthaei K.I., Foster P.S., and Rothenberg M.E. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 4 (2001) 594-601
18. Quntar A.A., and Srebnik M. Reactions of 1-alkynylphosphonates with group (IV) complexes. J. Organomet.Chem. (2004) 2504-2514
19. Quntar A.A., Dembitsky V.M., and Srebnik M. Novel one-pot synthesis of 3-amino-1-alkenylphophonates by Addition of imines to alkynylphosphonate titanium(II) complexes. Org. Lett. 5 (2003) 357-359
20. Quntar A.A., Rosental D., and Srebnik M. Synthesis of novel 5-hydroxyalkenylphosphonates by addition of aromatic aldehydes to zirconacyclopentenylphosphonates. Tetrahedron. 62 (2006) 5995-5999
21. 2 and oxyphenbutazone at 1.6 Å resolution. Biochemistry 43 (2004) 14577-14583
22. Thomas A.A., and Sharpless K.B. The catalytic asymmetric aminohydroxylation of unsaturated phosphonates. J. Org. Chem. 64 (1999) 8379-8385
23. Willard L.B., Hauss-Wegrzyniak B., and Wenk G.L. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88 (1999) 193-200